AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit


27 juni, 22:00

AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PR Newswire

NEW YORK, June 27, 2025

NEW YORK , June 27, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Apple Inc. ("Apple" or "the Company") (NASDAQ: AAPL) and certain of its officers.

Bronstein, Gewirtz & Grossman, LLC (PRNewsfoto/Bronstein, Gewirtz & Grossman, LLC)

Class Definition

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Apple securities between June 10, 2024 and June 9, 2025 , both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/AAPL.

Case Details

The complaint alleges defendants made false and/or misleading statements and/or failed to disclose that: (i) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (ii) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (iii) the lack of such advanced AI-based features would hurt iPhone 16 sales; (iv) as a result, Apple's business and/or financial prospects were overstated; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

What's Next?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/AAPL.  or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller , of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660 . If you suffered a loss in Apple you have until August 19, 2025 , to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn , X , Facebook , or Instagram .

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Nathan Miller

332-239-2660  | info@bgandg.com

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/aapl-investor-alert-bronstein-gewirtz--grossman-llc-announces-that-apple-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302490527.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

Läs mer på PR Newswire

Ämnen i artikeln

Apple

Senast

210,16

1 dag %

0,50%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.